10E8.4/iMab / Bill & Melinda Gates Foundation, IAVI, TaiMed Biologics 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    News 
  • ||||||||||  10E8.4/iMab / Bill & Melinda Gates Foundation, IAVI, TaiMed Biologics
    Clinical; Trial completion date; Trial primary completion date:  10E8.4/iMab Bispecific Antibody in HIV-uninfected and HIV-infected Adults (clinicaltrials.gov) -  Jan 25, 2021   
    P1,  N=63, Recruiting, 
    Trial completion date: Apr 2021 -> Apr 2022 | Trial primary completion date: Oct 2020 -> Oct 2021